Real-World Lab Data in Natalizumab Treated Multiple Sclerosis Patients Up to 6 Years Long-Term Follow Up

Authors
Category Primary study
JournalFrontiers in Neurology
Year 2018
This article has no abstract
Epistemonikos ID: 3dd0514ca25bf28bb41c4de5b33b142144ed8879
First added on: Feb 13, 2025